Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Manitoba

$17,500.00

Mechanism of cell death following exposure to the combination of Siramesine and Lapatinib

EF 2015-16

Résumé
Cancer is considered to be a modern epidemic. We can find new drugs to treat cancer by improving our understanding of what makes cancer cells different from normal body cells. How cells die is an important concept in cancer research. Normal cells die and are replaced as part of normal body processes. Cancer cells are often resistant to these normal cell death pathways. The goal of my research project is to understand one of these death pathways and to find ways to overcome that resistance to death. One of the recently identified pathways to cell death is called ferroptosis because iron is involved in the killing process. Two drugs, siramesine and lapatinib, act together to increase killing of breast cancer cells and this cell death appears to involve the iron-mediated pathway. I have shown that the combination of siramesine and lapatinib also kill lung and brain cancer cells. I will be examining aspects of ferroptosis to determine how this pathway is controlled in cancer cells. Better understanding of the ferroptosis pathway will help us to find drugs that can increase iron-mediated killing in cancer cells and improve cancer responses.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
349912
Name
Blankstein Anna
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Mechanism of cell death following exposure to the combination of Siramesine and Lapatinib
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Cell Death; Cell Signaling; Drug Targets; Ferroptosis; Lapatinib; Siramesine
Abstract
Cancer is considered to be a modern epidemic. We can find new drugs to treat cancer by improving our understanding of what makes cancer cells different from normal body cells. How cells die is an important concept in cancer research. Normal cells die and are replaced as part of normal body processes. Cancer cells are often resistant to these normal cell death pathways. The goal of my research project is to understand one of these death pathways and to find ways to overcome that resistance to death. One of the recently identified pathways to cell death is called ferroptosis because iron is involved in the killing process. Two drugs, siramesine and lapatinib, act together to increase killing of breast cancer cells and this cell death appears to involve the iron-mediated pathway. I have shown that the combination of siramesine and lapatinib also kill lung and brain cancer cells. I will be examining aspects of ferroptosis to determine how this pathway is controlled in cancer cells. Better understanding of the ferroptosis pathway will help us to find drugs that can increase iron-mediated killing in cancer cells and improve cancer responses.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Blankstein, Anna
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~